Johnson & Johnson Medical Devices — Goodwill (Note 3) decreased by 0.0% to $33.78B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $33.69B to $33.78B. Over 2 years (FY 2021 to FY 2024), Medical Devices — Goodwill (Note 3) shows an upward trend with a 45.6% CAGR.
An increase suggests recent acquisitions, while a decrease may indicate impairment charges or divestitures.
Represents the total carrying value of goodwill allocated to the MedTech operating segment as reported in the financial...
Standard across large-cap healthcare companies with M&A activity.
jnj_segment_medtech_goodwill_note_3| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.92B | $14.93B | $14.86B | $14.86B | $14.91B | $14.99B | $25.86B | $26.03B | $25.98B | $26.15B | $26.06B | $33.48B | $33.69B | $33.51B | $33.56B | $33.79B | $33.78B |
| QoQ Change | — | +0.1% | -0.4% | -0.0% | +0.4% | +0.5% | +72.6% | +0.7% | -0.2% | +0.7% | -0.3% | +28.5% | +0.6% | -0.5% | +0.2% | +0.7% | -0.0% |
| YoY Change | — | — | — | — | -0.0% | +0.4% | +74.0% | +74.6% | +73.3% | +1.1% | — | +28.6% | +29.7% | +28.1% | +28.8% | +0.9% | +0.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.